1832 Asset Management L.P.

Position in ARGX — Argenx SE

CIK 944388 TORONTO, A6

Position in ARGX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$146,531,993

+$85,044,943 QoQ

Shares Held

157,940

+87.6% QoQ

Ownership

0.254%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#31

of 505 holders

Holding Since

Sep 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

1832 Asset Management L.P. holds $312,434,848 across 9 Biotechnology names. ARGX ranks #1 (46.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE This page	157,940	$146,531,993
2	RVMD	Revolution Medicines, Inc.	309,200	$57,906,976
3	ARWR	Arrowhead Pharmaceuticals, Inc.	538,500	$43,893,135
4	KRYS	Krystal Biotech, Inc.	99,300	$36,906,831
5	TGTX	Tg Therapeutics, Inc.	186,300	$10,235,322
6	AXSM	Axsome Therapeutics, Inc.	28,000	$6,853,560
7	TVTX	Travere Therapeutics, Inc.	88,100	$5,004,961
8	INCY	Incyte Corp	42,067	$4,768,715

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$146,531,993	157,940	+87.6%	Shares	Sole	2026-08-13
2026-03-31	$61,487,050	84,200	-23.9%	Shares	Sole	2026-05-14
2025-12-31	$93,093,165	110,700	0.0%	Shares	Sole	2026-02-13
2025-09-30	$81,647,892	110,700	-35.8%	Shares	Sole	2025-11-14
2025-06-30	$95,030,328	172,400	-5.9%	Shares	Sole	2025-08-13
2025-03-31	$108,488,854	183,300	-11.6%	Shares	Sole	2025-05-14
2024-12-31	$127,489,500	207,300	+38.8%	Shares	Sole	2025-02-14
2024-09-30	$80,932,544	149,300	-30.5%	Shares	Sole	2024-11-13
2023-09-30	$105,602,124	214,800	-2.5%	Shares	Sole	2023-11-13
2023-06-30	$85,818,546	220,200	0.0%	Shares	Sole	2023-08-14
2023-03-31	$82,042,116	220,200	-0.5%	Shares	Sole	2023-05-12
2022-12-31	$83,797,196	221,200	+22.3%	Shares	Sole	2023-02-15
2022-09-30	$63,831,440	180,800	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.